CoChat

The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?

Moreno‐Sánchez, Rafael, Rodríguez‐Enríquez, Sara, Saavedra, Emma, Marín‐Hernández, Alvaro, Gallardo‐Pérez, Juan Carlos · 2009 · BioFactors
Cited by 129

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

The molecular mechanisms by which tumor cells achieve an enhanced glycolytic flux and, presumably, a decreased oxidative phosphorylation are analyzed. As the O 2 concentration in hypoxic regions of tumors seems not limiting for oxidative phosphorylation, the role of this mitochondrial pathway in the ATP supply is re‐evaluated. Drugs that inhibit glycoysis and oxidative phosphorylation are analyzed for their specificity toward tumor cells and effect on proliferation. The energy metabolism mechanisms involved in the use of positron emission tomography are revised and updated. It is proposed that energy metabolism may be an alternative therapeutic target for both hypoxic (glycolytic) and oxidative tumors. © 2009 International Union of Biochemistry and Molecular Biology, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biof.31

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 126

  1. 10.1126/science.123.3191.309 · DOI · Paper page
  2. 10.1111/j.1742-4658.2007.05686.x · DOI · Paper page
  3. Reske S. N., 1997, Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma, J. Nucl. Med., 38, 1344
  4. 10.4067/S0716-97602002000100004 · DOI · Paper page
  5. Noguchi Y., 1999, Expression of facilitative glucose transporters in gastric tumors, Hepatogastroenterology, 46, 2683
  6. 10.1677/joe.0.1820467 · DOI
  7. 10.1016/j.mce.2008.05.003 · DOI
  8. 10.1002/jcp.21166 · DOI
  9. Yeh C. S., 2008, Significance of the glycolytic pathway and glycolysis related‐genes in tumorigenesis of human colorectal cancers, Oncol. Rep., 19, 81
  10. 10.1111/j.1742-4658.2006.05214.x · DOI · Paper page
  11. 10.1016/0014-2964(78)90177-9 · DOI
  12. 10.1111/j.1349-7006.2007.00683.x · DOI
  13. 10.1080/02841850802482486 · DOI
  14. Vora S., 1985, Alterations in the activity and isozymic profile of human phosphofructokinase durig malignant transformation in vivo and in vitro: Transformation‐and progression‐linked discriminants of malignancy, Cancer Res., 45, 2993
  15. 10.1002/1097-0142(19910415)67:8<2153::AID-CNCR2820670825>3.0.CO;2-Z · doi:10.1002/1097-0142(19910415)67:8<2153::aid-cncr2820670825>3.0.co;2-z
  16. 10.1002/pmic.200401022 · DOI · Paper page
  17. 10.1158/1078-0432.CCR-06-0324 · DOI · Paper page
  18. Mikuriya K., 2007, Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidence by proteonomic profiling by two‐dimensional electrophoresis, Int. J. Oncol., 30, 849
  19. 10.1093/carcin/23.5.759 · DOI · Paper page
  20. 10.1038/sj.bjc.6603377 · DOI · Paper page
  21. 10.1073/pnas.0700690104 · DOI · Paper page
  22. 10.1038/sj.onc.1209604 · DOI · Paper page
  23. 10.1016/S1383-5742(01)00053-9 · DOI · Paper page
  24. 10.2174/1566524033361645 · DOI · Paper page
  25. Balinsky D., 1984, Enzyme activities in normal, dysplastic, and cancerous human breast tissues, J. Natl. Cancer. Inst., 72, 217
  26. 10.1016/j.semradonc.2004.04.004 · DOI · Paper page
  27. 10.1016/j.ygeno.2004.08.010 · DOI · Paper page
  28. 10.1074/jbc.M801765200 · DOI · Paper page
  29. 10.1016/j.ccr.2006.10.020 · DOI · Paper page
  30. 10.1074/jbc.C000023200 · DOI · Paper page
  31. 10.1042/BST0350305 · DOI
  32. 10.1128/MCB.25.14.6225-6234.2005 · DOI · Paper page
  33. 10.1038/sj.bjc.6601338 · DOI
  34. 10.1074/jbc.M211195200 · DOI
  35. 10.1038/sj.onc.1202746 · DOI · Paper page
  36. Robey I. F., 2008, Regulation of the Warburg effect in early‐passage breast cancer cells, Mol. Cell. Biol., 27, 7381
  37. 10.1042/bj1540449 · DOI · Paper page
  38. 10.1042/bj2340169 · DOI
  39. 10.1042/bj2600763 · DOI
  40. 10.1016/S0021-9258(18)47278-X · DOI · Paper page
  41. 10.1073/pnas.93.5.1847 · DOI · Paper page
  42. 10.1016/S0959-8049(00)00371-3 · DOI
  43. 10.1309/4KYNQM5862JW2GD7 · doi:10.1309/4kynqm5862jw2gd7 · Paper page
  44. 10.1016/S0005-2728(02)00248-7 · DOI · Paper page
  45. Geschwind J. F., 2002, Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production, Cancer Res., 62, 3909
  46. 10.1158/0008-5472.CAN-04-4313 · DOI
  47. 10.1042/BJ20080805 · DOI · Paper page
  48. 10.1002/mnfr.200700470 · DOI · Paper page
  49. 10.1016/S0014-5793(97)00496-1 · DOI
  50. 10.1042/bj2510677 · DOI · Paper page
  51. 10.1006/bbrc.2000.2681 · DOI
  52. Oskam R., 1985, Isozymic composition and regulatory properties of phosphofructokinase from well‐differentiated and anaplastic medullary thyroid carcinomas of the rat, Cancer Res., 45, 135
  53. Staal G. E. J., 1987, Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas, Cancer Res., 47, 5047
  54. 10.1007/s10585-005-2343-7 · DOI · Paper page
  55. Sonveaux P., 2008, Targeting lactate‐fueled respiration selectively kills hypoxic tumor cells in mice, J. Clin. Invest., 118, 3930
  56. 10.1159/000401202 · DOI · Paper page
  57. 10.4161/auto.2229 · DOI · Paper page
  58. 10.1080/15216540701509955 · DOI · Paper page
  59. Grogg K. L., 2002, Bronchial carcinoid tumor with crystalloid cytoplasmic inclusions, Arch. Pathol. Lab. Med., 126, 93, 10.5858/2002-126-0093-BCTWCC · doi:10.5858/2002-126-0093-bctwcc
  60. Morton R., 1976, Alteration of mitochondrial function and lipid composition in Morris 7777 hepatoma, Cancer Res., 36, 3246
  61. 10.1038/sj.bjc.6603886 · DOI · Paper page
  62. 10.1038/sj.onc.1209607 · DOI · Paper page
  63. 10.1038/nrc1737 · DOI · Paper page
  64. 10.1016/j.abb.2007.02.033 · DOI · Paper page
  65. 10.1002/pros.20617 · DOI
  66. 10.1016/j.taap.2006.02.005 · DOI
  67. 10.1042/bj3640309 · DOI · Paper page
  68. 10.1186/1476-4598-5-14 · DOI · Paper page
  69. 10.1016/j.bbamem.2007.02.018 · DOI
  70. 10.1016/j.bbamem.2007.12.013 · DOI
  71. Rofstad E. R., 2000, Vascular endothelial growth factor, interleukin 8, platelet‐derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts, Cancer Res., 60, 4932
  72. 10.1016/0925-4439(94)90085-X · DOI
  73. 10.1016/S0360-3016(98)00020-0 · DOI
  74. 10.1016/j.ijrobp.2007.04.067 · DOI
  75. Vaupel P., 1991, Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancer by computerized O2 tension measurements, Cancer Res., 51, 3316
  76. Erickson K., 2003, Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation, Cancer Res., 63, 4705
  77. Kolstad P., 1968, Intercapillary distance, oxygen tension and local recurrence in cervix cancer, Scand. J. Clin. Lab. Invest. Suppl., 196, 145, 10.1080/00365516809168210 · DOI · Paper page
  78. Kallinowski F., 1989, Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts, Cancer Res., 49, 3759
  79. 10.1002/(SICI)1099-1492(199605)9:3<125::AID-NBM405>3.0.CO;2-F · DOI
  80. 10.1667/0033-7587(2001)156[0510:TODWRT]2.0.CO;2 · DOI
  81. 10.1529/biophysj.106.099135 · DOI
  82. 10.1016/0006-3002(62)91158-7 · DOI
  83. 10.1242/jeb.201.8.1129 · DOI · Paper page
  84. 10.1152/ajpcell.00286.2004 · DOI
  85. 10.1042/bj3130809 · DOI · Paper page
  86. 10.1046/j.1471-4159.2001.00214.x · DOI · Paper page
  87. 10.1111/j.1432-1033.1986.tb10496.x · DOI · Paper page
  88. 10.1016/j.bbrc.2003.11.136 · DOI · Paper page
  89. Nakashima R. A., 1984, Contributions of glycolysis and oxidative phosphorylation to adenosine 5′‐triphosphate production in AS‐30D hepatoma cells, Cancer Res., 44, 5702
  90. Fell D., 1997, Understanding the control of metabolism
  91. 10.1155/2008/597913 · DOI · Paper page
  92. 10.1006/abbi.1999.1582 · DOI
  93. 10.1007/s11060-004-6404-6 · DOI · Paper page
  94. 10.1002/jcb.21280 · DOI · Paper page
  95. Newell K. J., 1989, Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide‐3‐chlorophenylhydrazone, Cancer Res., 49, 4477
  96. 10.1002/jcp.21392 · DOI · Paper page
  97. Murphy B. J., 1993, Enhancement of heme oxygenase expression and activity in A431 squamous carcinoma multicellular tumor spheroids, Cancer Res., 53, 2700
  98. 10.1016/0014-4827(91)90140-P · DOI
  99. 10.1002/cbf.290100110 · DOI
  100. 10.1002/pmic.200300796 · DOI
  101. Walenta S., 2000, High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers, Cancer Res., 60, 916
  102. Peng S. Y., 2008, Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis, Oncol. Rep., 19, 1045
  103. 10.1002/jcp.1041030121 · doi:10.1002/jcp.1041030121
  104. 10.1038/sj.onc.1209602 · DOI
  105. 10.1046/j.1365-2141.1996.d01-1951.x · doi:10.1046/j.1365-2141.1996.d01-1951.x
  106. 10.1096/fj.02-0541com · DOI · Paper page
  107. Koya K., 1996, MKT‐077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation, Cancer Res., 56, 538
  108. 10.1006/abbi.1994.1122 · DOI
  109. 10.1016/S0006-2952(00)00513-X · DOI
  110. 10.2174/1568009043332943 · DOI
  111. 10.1016/S0969-8051(00)00177-3 · DOI
  112. 10.1146/annurev.med.53.082901.104028 · DOI · Paper page
  113. 10.2174/1568009043332943 · DOI
  114. 10.3348/kjr.2006.7.1.57 · DOI · Paper page
  115. Kubota R., 1994, Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine‐18‐ fluorodeoxyglucose uptake, J. Nucl. Med., 35, 104
  116. Higashi K., 1998, Fluorine‐18‐FDG PET imaging is negative in bronchioloalveolar lung carcinoma, J. Nucl. Med., 39, 1016
  117. Han H. S., 2009, High incidence of false positive PET scans in patients with aggressive non‐Hodgkins lymphoma treated with rituximab‐containing regimens, Ann. Oncol., 2, 309, 10.1093/annonc/mdn629 · DOI
  118. 10.1007/s10147-006-0595-0 · DOI
  119. Torizuka T., 1995, In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG/PET, J. Nucl. Med., 36, 1811
  120. 10.1097/01.mnm.0000136693.94761.5c · doi:10.1097/01.mnm.0000136693.94761.5c
  121. 10.1007/s00259-006-0175-6 · DOI
  122. 10.1007/s10350-008-9420-3 · DOI · Paper page
  123. 10.1007/BF03165001 · doi:10.1007/bf03165001
  124. 10.1053/j.semnuclmed.2005.09.001 · DOI
  125. 10.1038/sj.pcan.4500879 · DOI · Paper page
  126. 10.1001/jama.293.5.615 · DOI

Cited by

See all 129

Metadata

Authors
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Saavedra, E., Marín‐Hernández, A., & Gallardo‐Pérez, J. C.
Venue
BioFactors
Publisher
Wiley
Published
2009-03
Volume
35
Issue
2
Pages
209-225
ISSN
  • 0951-6433 (ISSN-L)
  • 1872-8081
OpenAlex
W1996447891
Cited by
129
References
23
FWCI
2.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? https://app.cochat.ai/papers/10.1002/biof.31
The paper
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Saavedra, E., Marín‐Hernández, A., & Gallardo‐Pérez, J. C. (2009). The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? BioFactors. https://doi.org/10.1002/biof.31

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.